Kardium Globe® Mapping and Ablation System Begins Clinical Trial at St. Paul’s Hospital

A revolutionary device that treats Atrial Fibrillation (AF) – the world's most common heart rhythm disorder – helps support the healthy aging of BC's population.

Kardium Inc. announces a successful first-in-BC investigational* clinical procedure using the Globe® Mapping and Ablation System.

Dr. Marc Deyell of St. Paul’s Hospital leads the study using the Globe System to navigate inside the heart and diagnose where the rhythm disturbances occur. Once identified, the same device can then deliver immediate treatment to restore the normal heart rhythm and confirm successful treatment.

“Atrial fibrillation can severely impact quality of life for patients, and physicians are always seeking out the best tools to treat this disorder,” says Dr. Deyell. “The Globe System allows me to quickly map and diagnose the electrical disturbances in the heart and then rapidly treat them, all with the same system. This all-in-one system is revolutionary and has the potential to reduce procedure complexity, time and increase procedural success. The potential for improved outcomes benefits patients, hospitals and the health system.”

“Partnerships between clinician-researchers and the technology sector can accelerate innovation and advancements in patient care. As a Vancouver-based company, we are delighted to be working with Dr. Deyell at St. Paul’s Hospital – home of the provincial Heart Centre – and the Centre for Cardiovascular Innovation at the University of British Columbia to conduct this study with the Globe System right here in BC,” said Kevin Chaplin, CEO of Kardium. “Since our successful commercial launch of the Globe System in Europe, our goal has been to make the technology available in North America.”

As Associate Professor of Medicine at the University of British Columbia and Director of Heart Rhythm Research and Electrophysiology Laboratory at St. Paul’s Hospital, Dr. Deyell’s clinical and research interests include complex arrhythmia treatment and ablation.

Kardium describes the Globe System as an all-in-one solution for treating atrial fibrillation, affecting more than 59 million people worldwide and approximately 200,000 in Canada1,2. The Globe System is a single catheter solution for high-definition mapping and ablation. The Globe Catheter has 122 electrodes that allow for rapid, single-shot pulmonary vein isolation (PVI), high-definition mapping in real-time, and atrial ablation.

A world-class hospital located in the heart of Vancouver, St. Paul’s Hospital provides exceptional clinical care to 500,000+ patient visits each year; performs medical research that advances care around the world; and, as a teaching hospital, trains the health care professionals of tomorrow. Many medical researchers at St. Paul’s Hospital rank among the world’s best in their fields, including heart, lung, renal, HIV/AIDS, and seniors care. Since its founding in 1894, St. Paul’s Hospital has provided innovative and compassionate patient care. Today, it is one of the world’s great health care centres.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides our readership with breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The ArthroFree system is the first FDA-cleared wireless camera for arthroscopy and general endoscopy, both areas of minimally invasive surgery. The system is designed to help surgeons work with aximum dexterity and focus.
The project, which was led by the University of Southern California, included large increases in representation among men of African, Hispanic and Asian ancestries, that were contributed in part by an ongoing collaboration between the U.S. Department of Veterans Affairs and DOE reports Argonne.
This innovative software turns smartphones into medical-grade stethoscopes, allowing people to capture, analyze, and share critical heart health data with medical personnel from the comfort of any location notes Sparrow BioAcoustics.
"Taewoong Medical becoming an Olympus group company is also a major milestone in our global growth strategy," said Henry Shin, CEO of STARmed. "We look forward to our products being made available to more patients through Olympus' global distribution network."
The company reports they have successfully met the six-month primary endpoint for the first-ever female patient implanted with the UroActive™ System, the first smart automated artificial urinary sphincter (AUS) to treat SUI.

By using this website you agree to accept Medical Device News Magazine Privacy Policy